We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App




Next-Generation Hemoglobin Analyzer Uniquely Ensures Bi-Directional Data Management Future Proofing

By LabMedica International staff writers
Posted on 04 May 2015
Print article
Image: The new point-of-care Hemo Control delivers laboratory-accurate hemoglobin and hematocrit results in one simple test and uniquely offers flexible and enhanced data management with bi-directional interface (Photo courtesy of EKF Diagnostics).
Image: The new point-of-care Hemo Control delivers laboratory-accurate hemoglobin and hematocrit results in one simple test and uniquely offers flexible and enhanced data management with bi-directional interface (Photo courtesy of EKF Diagnostics).
A new point-of-care (POC) diagnostics analyzer delivers quantitative laboratory-accurate hemoglobin and hematocrit results in one simple test and uniquely enables upgrade with data management functionality as required, giving broad flexibility over future connectivity options via its bi-directional interface.

The new robust, portable Hemo Control from EKF Diagnostics (Cardiff, UK) provides accuracy and reliability of results (imprecision of <2%) from 25 seconds for blood banks, hospitals, and clinics. It can easily communicate with in-house systems: using the new LIS2-A2 communication standard, this bi-directional interface allows the analyzer to connect directly to third party software and enable simple integration with LIS (Laboratory Information System) middleware. (LIS2-A2 succeeds the ASTM communication standard commonly used for small to mid-size analyzers and is easier to integrate than POCT-1A.)

This cost-effective basic device stores up to 4,000 patient results and offers enhanced on-board Data Management (DM) functions following upgrade with the DM “add pack” if required at a later date. In addition to enabling lists to be sent directly from the LIS to Hemo Control, DM upgrade also offers barcode identification of patients, operators, cuvette LOT and control materials, as well as quality control with lock-out functions and ability to add comments to results. Hemo Control requires no docking station when handling on-board data management as it uses simple cable connections (e.g. RS-232 to USB or LAN), or integrated Bluetooth technology available with Hemo Control Manager—the top-of-the-range device available with preinstalled DM functions.

“Our new Hemo Control with flexible DM upgrade and bi-directional connectivity is ideal for customers who wish to keep their connectivity options open. This may be because they are planning on future connection of POC devices to the LIS but have yet to decide, or they may need to split costs for budgetary reasons by upgrading at a later date,” said Katja Lemburg, global product manager for hematology.

This compact analyzer is user friendly with step-by-step on-screen instructions, needs no calibration or maintenance, and requires minimal user training. Furthermore, Hemo Control uses NXT shape microcuvette technology, which enables improved finger stick sample collection by virtually eliminating appearance of air bubbles.

Related Links:

EKF Diagnostics
Hemo Control with “Add Pack” options



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.